» Articles » PMID: 6165428

Toxicity of Interferon

Overview
Specialty General Medicine
Date 1981 Apr 25
PMID 6165428
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of partially purified human leucocyte interferon (PIF) and of a preparation purified by passage twice through a monoclonal antibody affinity chromatography column (NK21F) were compared with those of a control solution in healhty volunteers. After intramuscular injections both interferon preparations caused rises in pulse rate and body temperature, changes in circulating white cell counts, and various unpleasant symptoms, the most common of which were headache, malaise, and fever. Slightly lower doses of NK21F were given, and this was reflected in lower peak serum concentrations. Mean symptom scores, however, were not lower after NK21F than after PIF. Local inflammatory reactions eight hours after intradermal inoculations of these interferons were similar. Purification of interferon using a monoclonal antibody does not reduce the facets of its activity considered in this study. They are therefore inherent in the leucocyte interferon type selected by the antibody.

Citing Articles

Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice.

Laino J, Wangorsch A, Blanco F, Wolfheimer S, Krause M, Flaczyk A J Immunol Res. 2017; 2017:7983217.

PMID: 29204451 PMC: 5674512. DOI: 10.1155/2017/7983217.


Risks and benefits of interferon-alpha in the treatment of hepatitis.

Pardo M, Marriott E, Moliner M, Quiroga J, Carreno V Drug Saf. 1995; 13(5):304-16.

PMID: 8785018 DOI: 10.2165/00002018-199513050-00004.


Human leukocyte interferon-alpha in cream, for the treatment of genital warts in Asian women: a placebo-controlled, double-blind study.

Syed T, Lundin S, Cheema K, Kahlon B, Cheema R, Ahmad S Clin Investig. 1994; 72(11):870-3.

PMID: 7894214 DOI: 10.1007/BF00190743.


Management of genital warts in women with human leukocyte interferon-alpha vs. podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study.

Syed T, Khayyami M, Kriz D, Svanberg K, Kahlon R, Ahmad S J Mol Med (Berl). 1995; 73(5):255-8.

PMID: 7670929 DOI: 10.1007/BF00189926.


Human leukocyte interferon-alpha in cream for the management of genital herpes in Asian women: a placebo-controlled, double-blind study.

Syed T, Lundin S, Cheema K, Kahlon R, Khayyami M, Ahmad S J Mol Med (Berl). 1995; 73(3):141-4.

PMID: 7633951 DOI: 10.1007/BF00198242.


References
1.
Scott G, Tyrrell D . Interferon: therapeutic fact or fiction for the '80s?. Br Med J. 1980; 280(6231):1558-62. PMC: 1601917. DOI: 10.1136/bmj.280.6231.1558. View

2.
Sikora K . Does interferon cure cancer?. Br Med J. 1980; 281(6244):855-8. PMC: 1714259. DOI: 10.1136/bmj.281.6244.855. View

3.
Scott G, Stewart 2nd W, Tyrrell D, Cantell K, Cartwright T, Edy V . Skin reactions to interferon inoculations are reduced but not abolished by purification. J Interferon Res. 1980; 1(1):79-86. DOI: 10.1089/jir.1980.1.79. View

4.
Atherton K, Burke D . Interferon induction by viruses and polynucleotides: a differential effect of comptothecin. J Gen Virol. 1975; 29(3):297-304. DOI: 10.1099/0022-1317-29-3-297. View

5.
Secher D, Burke D . A monoclonal antibody for large-scale purification of human leukocyte interferon. Nature. 1980; 285(5765):446-50. DOI: 10.1038/285446a0. View